Christina Izzo

Articles by Christina Izzo

The FDA has approved pembrolizumab (Keytruda) for the treatment of advanced melanoma, making it the first PD-1 inhibitor to receive approval in the United States and marking yet another milestone breakthrough for patients who once had little hope of surviving this disease.

Researchers at The University of Texas at Austin have found that postmenopausal overweight or obese breast cancer patients receiving hormone therapy as part of their treatment who use nonsteroidal anti-inflammatory drugs (NSAIDs) have significantly lower breast cancer recurrence rates and a sizable delay in time to cancer recurrence.

A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has shown that electroacupuncture produces significant improvements in fatigue, anxiety, and depression in as little as 8 weeks for early-stage breast cancer patients experiencing joint pain related to the use of aromatase inhibitors (AIs).